Multidrug resistance in Yersinia pestis mediated by a transferable plasmid.

Yersinia pestis is the causative agent of plague, a zoonotic disease transmitted to humans through flea bites and typically characterized by the appearance of a tender and swollen lymph node, the bubo. Human-to-human transmission can occur, through either the bite of fleas (bubonic plague) or respiratory droplets, causing an overwhelming infection called pneumonic plague. The last plague pandemic began in Hong Kong in 1894 and spread throughout the world, establishing many endemic foci. Antibiotics and enforcement of public health measures significantly decreased the morbidity and mortality associated with the disease but did not allow its eradication. In fact, plague . . .

[1]  P. Trieu-Cuot,et al.  Transferable plasmid-mediated antibiotic resistance in Listeria monocytogenes , 1990, The Lancet.

[2]  J. Wain,et al.  In vitro antimicrobial susceptibilities of strains of Yersinia pestis , 1995, Antimicrobial agents and chemotherapy.

[3]  J. Frean,et al.  In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus , 1996, Antimicrobial agents and chemotherapy.

[4]  P. H. Roy,et al.  Characterization of In0 of Pseudomonas aeruginosa plasmid pVS1, an ancestor of integrons of multiresistance plasmids and transposons of gram-negative bacteria , 1992, Journal of bacteriology.

[5]  N. Datta,et al.  Plasmid-determined fusidic acid resistance in the Enterobacteriaceae. , 1974, Journal of general microbiology.

[6]  L. Garrod,et al.  Methods of testing combined antibiotic bactericidal action and the significance of the results , 1962, Journal of clinical pathology.

[7]  S. Schrag,et al.  Emerging infectious disease: what are the relative roles of ecology and evolution? , 1995, Trends in ecology & evolution.

[8]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[9]  W. V. Shaw,et al.  Resistance to fusidic acid in Escherichia coli mediated by the type I variant of chloramphenicol acetyltransferase. A plasmid-encoded mechanism involving antibiotic binding. , 1983, The Biochemical journal.

[10]  W. V. Shaw,et al.  Plasmid-Mediated Mechanisms of Resistance to Aminoglycoside-Aminocyclitol Antibiotics and to Chloramphenicol in Group D Streptococci , 1978, Antimicrobial Agents and Chemotherapy.

[11]  W. Wood,et al.  Host specificity of DNA produced by Escherichia coli: bacterial mutations affecting the restriction and modification of DNA. , 1966, Journal of molecular biology.

[12]  M. Couturier,et al.  Cloning and characterization of the Inc A/C plasmid RA1 replicon , 1994, Journal of bacteriology.

[13]  M. Haas,et al.  Aminoglycoside-modifying enzymes. , 1975, Methods in enzymology.

[14]  R. Brubaker,et al.  Plasmids in Yersinia pestis , 1981, Infection and immunity.

[15]  J. Sutcliffe,et al.  Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. , 1978, Proceedings of the National Academy of Sciences of the United States of America.